{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:12:50Z","timestamp":1795043570319,"version":"4.10.2"},"reference-count":24,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.metabol.2006.02.024","type":"journal-article","created":{"date-parts":[[2006,6,19]],"date-time":"2006-06-19T09:44:00Z","timestamp":1150710240000},"page":"940-945","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Lipodystrophy and metabolic syndrome in HIV-infected patients treated with antiretroviral therapy"],"prefix":"10.1016","volume":"55","author":[{"given":"Vicente","family":"Estrada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Teresa","family":"Mart\u00ednez-Larrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Gonz\u00e1lez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noem\u00ed G.P.","family":"de Villar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Zabena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Serrano-R\u00edos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2006.02.024_bib1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","article-title":"Definition of metabolic syndrome. Report of the National Heart, Lung and Blood Institute\/American Heart Association Conference on Scientific Issues Related to Definition","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2006.02.024_bib2","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1097\/00004872-200307000-00028","article-title":"Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome","volume":"21","author":"Gazzaruso","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.metabol.2006.02.024_bib3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00126334-200211010-00015","article-title":"High prevalence of metabolic syndrome among HIV-infected patients: link with the cardiovascular risk","volume":"31","author":"Bruno","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.metabol.2006.02.024_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/01.ATV.0000099786.99623.EF","article-title":"Adiponectin and metabolic syndrome","volume":"24","author":"Matsuzawa","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2006.02.024_bib5","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1210\/er.2002-0010","article-title":"Insulin resistance and chronic cardiovascular inflammatory syndrome","volume":"24","author":"Fernandez-Real","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2006.02.024_bib6","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1253\/circj.68.975","article-title":"Adiponectin as a biomarker of the metabolic syndrome","volume":"68","author":"Ryo","year":"2004","journal-title":"Circ J"},{"key":"10.1016\/j.metabol.2006.02.024_bib7","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/135965350400900412","article-title":"Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1\u2013infected lipodystrophic patients","volume":"9","author":"Jan","year":"2004","journal-title":"Antivir Ther"},{"key":"10.1016\/j.metabol.2006.02.024_bib8","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/00002030-200307040-00011","article-title":"Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy","volume":"17","author":"Vigouroux","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.metabol.2006.02.024_bib9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1157\/13080210","article-title":"Prevalencia del s\u00edndrome metab\u00e1lico (criterios del ATP-III). Estudio de base poblacional en \u00e1reas rural y urbana de la provincia de Segovia","volume":"125","author":"Martinez Larrad","year":"2005","journal-title":"Med Clin"},{"key":"10.1016\/j.metabol.2006.02.024_bib10","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-Moller","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2006.02.024_bib11","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/368185","article-title":"Prediction of coronary heart disease risk in HIV-infected patients with fat redistribution","volume":"36","author":"Hadigan","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.metabol.2006.02.024_bib12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2337\/diacare.28.1.132","article-title":"Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors","volume":"28","author":"Jerico","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2006.02.024_bib13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1086\/317541","article-title":"Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy","volume":"32","author":"Hadigan","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.metabol.2006.02.024_bib14","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0735-1097(02)02051-X","article-title":"Relationship between obesity, insulin resistance, and coronary heart disease risk","volume":"40","author":"Abbasi","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2006.02.024_bib15","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/00002030-200307040-00011","article-title":"Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy","volume":"17","author":"Vigouroux","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.metabol.2006.02.024_bib16","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1177\/135965350400900607","article-title":"Antiretroviral drugs with adverse effects on adipocyte lipid metabolism and survival alter the expression and secretion of proinflammatory cytokines and adiponectin in vitro","volume":"9","author":"Lagathu","year":"2004","journal-title":"Antivir Ther"},{"key":"10.1016\/j.metabol.2006.02.024_bib17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00125-003-1074-z","article-title":"Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex","volume":"46","author":"Cnop","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2006.02.024_bib18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00042560-200201010-00004","article-title":"Leptin and adipose tissue maldistribution in HIV-infected male patients with predominant fat loss treated with antiretroviral therapy","volume":"29","author":"Estrada","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.metabol.2006.02.024_bib19","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1086\/367859","article-title":"Human immunodeficiency virus type 1\u2013related lipoatrophy and lipohypertrophy are associated with serum concentrations of leptin","volume":"36","author":"Nagy","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.metabol.2006.02.024_bib20","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/ajcn\/79.6.1103","article-title":"Relation of leptin pulse dynamics to fat distribution in HIV-infected patients","volume":"79","author":"Koutkia","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.metabol.2006.02.024_bib21","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.tem.2003.09.008","article-title":"Lipid overload and overflow: metabolic trauma and the metabolic syndrome","volume":"14","author":"Unger","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.metabol.2006.02.024_bib22","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","article-title":"Leptin-replacement therapy for lipodystrophy","volume":"346","author":"Oral","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2006.02.024_bib23","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1210\/jc.2002-020709","article-title":"Sustained benefits of metformin therapy on markers of cardiovascular risk in human immunodeficiency virus\u2013infected patients with fat redistribution and insulin resistance","volume":"87","author":"Hadigan","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2006.02.024_bib24","doi-asserted-by":"crossref","first-page":"786","DOI":"10.7326\/0003-4819-140-10-200405180-00008","article-title":"Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized, controlled trial","volume":"140","author":"Hadigan","year":"2004","journal-title":"Ann Intern Med"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049506000862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049506000862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:14:18Z","timestamp":1758424458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049506000862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0026049506000862"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2006.02.024","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipodystrophy and metabolic syndrome in HIV-infected patients treated with antiretroviral therapy","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2006.02.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}